<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04259437</url>
  </required_header>
  <id_info>
    <org_study_id>BL44</org_study_id>
    <nct_id>NCT04259437</nct_id>
  </id_info>
  <brief_title>Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition</brief_title>
  <official_title>A Study to Evaluate the Gastrointestinal Tolerance and Acceptability of a High Energy, High Protein Low Volume Oral Nutritional Supplement in Adult Patients With or at Risk of Malnutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the GI tolerance, palatability and compliance to a
      high protein energy-dense oral nutrition supplement in adult patients with or at risk of
      malnutrition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastro-Intestinal Tolerance</measure>
    <time_frame>Day 1 to Day 7</time_frame>
    <description>Subject completed Bristol Stool Type questionnaire; Stool is classified into 7 groups (Types 1-7) with Type 3-4 as ideal stools.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nutritional Supplement Palatability</measure>
    <time_frame>Day 1 to Day 7</time_frame>
    <description>Subject completed 6, Likert Scale questions; 4 scaled in the negative direction; 2 scaled from Far Too to Not at all Enough</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nutritional Supplement Intake</measure>
    <time_frame>Day 1 to Day 7</time_frame>
    <description>Subject completed daily intake questionnaire including amount of Bottle 1 and Bottle 2 consumed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nutritional Supplement Palatability</measure>
    <time_frame>Day 7</time_frame>
    <description>Subject completed 6, Likert Scale questions; 4 scaled in the negative direction; 2 scaled from Far Too to Not at all Enough for additional flavors</description>
  </primary_outcome>
  <other_outcome>
    <measure>Medications</measure>
    <time_frame>Baseline to Day 7</time_frame>
    <description>Subject reported medication usage</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline and Day 7</time_frame>
    <description>For BMI Calculation</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastro-Intestinal Tolerance</condition>
  <arm_group>
    <arm_group_label>High Protein, Energy Dense Nutritional Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 servings per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Protein, Energy Dense Nutritional Supplement</intervention_name>
    <description>Ready to drink oral supplement</description>
    <arm_group_label>High Protein, Energy Dense Nutritional Supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has voluntarily signed and dated informed consent form approved by Independent
             Ethics Committee and provided applicable privacy authorization prior to any
             participation in the study.

          -  Subject is considered malnourished or at risk for malnutrition

          -  Subject has normal GI function

          -  Subject requires oral nutritional supplementation ands is willing to comply with the
             study protocol

        Exclusion Criteria:

          -  Subject has severe dementia, eating disorder, history of significant neurological or
             psychiatric disorder affecting abilities to answer questions, alcoholism, substance
             abuse or other conditions that may interfere with study product consumption or
             compliance with study protocol procedures

          -  Subject has a history of diabetes

          -  Subject is currently taking antibiotics or has taken antibiotics within 1 week prior
             to enrollment

          -  Subject has undergone major GI surgery less than 3 months prior to enrollment

          -  Subject has active malignant disease or was treated within the last 6 months for
             cancer

          -  Subject has immunodeficiency disorder

          -  Subject has had a myocardial infarction within the last 3 months prior to enrollment

          -  Subject is known to be allergic to intolerant to an ingredient found in the study
             product

          -  Subject has an aversion to the flavor of product being tested

          -  Subject has an obstruction of the GI tract precluding ingestion or absorption of the
             study product, inflammatory bowel disease, gastric esophageal reflux disease, short
             bowel syndrome, or other major gastro-intestinal disease-causing symptoms including
             but not limited to uncontrollable severe diarrhea, nausea, or vomiting

          -  Subject is taking medications/dietary supplements/substances that could profoundly
             modulate metabolism or affect gastrointestinal motility.

          -  Participation in another study that has not yet been approved as a concomitant study
             by the Sponsor.

          -  Subject has a clinical condition that is contraindicated with this product.

          -  Subject is pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Camprubi Robles, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RDN, LD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Adam Practice</name>
      <address>
        <city>Poole</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 29, 2020</study_first_submitted>
  <study_first_submitted_qc>February 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

